Literature DB >> 29344850

HuR facilitates cancer stemness of lung cancer cells via regulating miR-873/CDK3 and miR-125a-3p/CDK3 axis.

Yu Zhang1,2, Limin Yang1, Chunhua Ling3, Wei Heng4.   

Abstract

OBJECTIVES: To study the roles and mechanisms of HuR in cancer stem cell maintenance of lung cancer.
RESULTS: HuR expression was increased in tumor spheres of lung cancer cells. Knockdown of HuR suppressed spheroid formation and size, inhibited the expression of stemness-related marker, Oct4, Nanog and ALDH in lung cancer cells. Importantly, HuR and CDK3 expressions were increased in lung cancer tissues compared with normal adjacent tissues, and positively correlated. Mechanistically, HuR directly bound to CDK3, and increased CDK3 mRNA stability and expression. Additionally, miR-873 or miR-125a-3p attenuated the promotion of HuR on CDK3 expression and lung cancer stemness. Furthermore, HuR facilitated lung cancer stemness dependent on CDK3 expression. miR-873 or miR-125a-3p level was negatively correlated with HuR and CDK3 expression levels in lung cancer tissues.
CONCLUSIONS: HuR facilitates lung cancer stemness via regulating miR-873/CDK3 and miR-125a-3p/CDK3 axis.

Entities:  

Keywords:  CDK3; HuR; Lung cancer; Stemness; miR-125a-3p; miR-873

Mesh:

Substances:

Year:  2018        PMID: 29344850     DOI: 10.1007/s10529-018-2512-9

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  12 in total

1.  RNA-binding protein PUM2 suppresses osteosarcoma progression via partly and competitively binding to STARD13 3'UTR with miRNAs.

Authors:  Ruixi Hu; Xiaodong Zhu; Chao Chen; Ruijun Xu; Yifan Li; Wei Xu
Journal:  Cell Prolif       Date:  2018-08-07       Impact factor: 6.831

Review 2.  Drug delivery approaches for HuR-targeted therapy for lung cancer.

Authors:  Rajeswari Raguraman; Santny Shanmugarama; Meghna Mehta; Jo Elle Peterson; Yan D Zhao; Anupama Munshi; Rajagopal Ramesh
Journal:  Adv Drug Deliv Rev       Date:  2021-11-22       Impact factor: 15.470

3.  Comprehensive Analysis of Role of Cyclin-Dependent Kinases Family Members in Colorectal Cancer.

Authors:  Liping Guan; Yuanyuan Tang; Guanghua Li; Zhao Qin; Shaoshan Li
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

Review 4.  A review on the role of cyclin dependent kinases in cancers.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Peixin Dong; Nikolaus Gassler; Mohammad Taheri; Aria Baniahmad; Nader Akbari Dilmaghani
Journal:  Cancer Cell Int       Date:  2022-10-20       Impact factor: 6.429

5.  The tumor-suppressive role of microRNA-873 in nasopharyngeal carcinoma correlates with downregulation of ZIC2 and inhibition of AKT signaling pathway.

Authors:  Baotao Lv; Fuzhou Li; Xiaoli Liu; Liqiang Lin
Journal:  Cancer Gene Ther       Date:  2020-06-18       Impact factor: 5.987

6.  Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells.

Authors:  Xiumei Zhang; Bingfeng Zhang; Panhong Zhang; Lihui Lian; Lianlian Li; Zhihong Qiu; Kai Qian; An Chen; Qiongqing Liu; Yinjie Jiang; Jiajun Cui; Bing Qi
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

Review 7.  Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies.

Authors:  Abdul Q Khan; Eiman I Ahmed; Noor R Elareer; Kulsoom Junejo; Martin Steinhoff; Shahab Uddin
Journal:  Cells       Date:  2019-08-05       Impact factor: 6.600

8.  MicroRNA-139-3p Inhibits The Growth And Metastasis Of Ovarian Cancer By Inhibiting ELAVL1.

Authors:  Fang Xue; Qi Rong Li; Yan Hua Xu; Hai Bin Zhou
Journal:  Onco Targets Ther       Date:  2019-11-05       Impact factor: 4.345

9.  Silencing of HuR Inhibits Osteosarcoma Cell Epithelial-Mesenchymal Transition via AGO2 in Association With Long Non-Coding RNA XIST.

Authors:  Yongming Liu; Yuan Zhang; Jinxue Zhang; Jingchang Ma; Xuexue Xu; Yuling Wang; Ziqing Zhou; Dongxu Jiang; Shen Shen; Yong Ding; Yong Zhou; Ran Zhuang
Journal:  Front Oncol       Date:  2021-03-19       Impact factor: 6.244

10.  Downregulated Expression of hsa_circ_0005556 in Gastric Cancer and Its Clinical Significance.

Authors:  Liangwei Yang; Yu Yu; Xiuchong Yu; Jiaming Zhou; Zhiping Zhang; Shibo Ying; Junming Guo; Zhilong Yan
Journal:  Dis Markers       Date:  2019-11-19       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.